Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
Authors
Keywords
-
Journal
Journal of Immunotoxicology
Volume 10, Issue 3, Pages 321-328
Publisher
Informa UK Limited
Online
2012-11-23
DOI
10.3109/1547691x.2012.741628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
- (2012) Wei Xiong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
- (2011) Jaume Sastre-Garriga et al. Expert Review of Neurotherapeutics
- Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death
- (2011) Partha Mukhopadhyay et al. FREE RADICAL BIOLOGY AND MEDICINE
- A Cannabinoid Ligand, Anandamide, Exacerbates Endotoxin-Induced Uveitis in Rabbits
- (2011) Ali Altinsoy et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plasma Cannabinoid Pharmacokinetics following Controlled Oral 9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
- (2010) E. L. Karschner et al. CLINICAL CHEMISTRY
- Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications
- (2010) N. T. Snider et al. PHARMACOLOGICAL REVIEWS
- Variation of lipopolysaccharide-induced acute lung injury in eight strains of mice
- (2010) Ann-Sophie Alm et al. RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
- (2009) Sagnik Bhattacharyya et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
- (2009) Teresa Iuvone et al. CNS Neuroscience & Therapeutics
- Varying susceptibility of pulmonary cytokine production to lipopolysaccharide in mice
- (2009) Ann-Sophie Alm et al. CYTOKINE
- A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
- (2009) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
- (2008) Barbara L.F. Kaplan et al. BIOCHEMICAL PHARMACOLOGY
- Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Δ9 -tetrahydrocannabinol
- (2008) Alison E. B. Springs et al. JOURNAL OF LEUKOCYTE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More